Bell Investment Advisors’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.47K Hold
26
﹤0.01% 941
2026
Q1
$5.75K Sell
26
-13
-33% -$3.18K ﹤0.01% 902
2025
Q4
$9.89K Buy
39
+11
+39% +$2.76K ﹤0.01% 698
2025
Q3
$6.93K Buy
28
+2
+8% +$479 ﹤0.01% 777
2025
Q2
$6.25K Buy
26
+2
+8% +$466 ﹤0.01% 886
2025
Q1
$5.44K Hold
24
﹤0.01% 871
2024
Q4
$4.93K Sell
24
-7
-23% -$1.54K ﹤0.01% 932
2024
Q3
$7.52K Sell
31
-3
-9% -$702 ﹤0.01% 744
2024
Q2
$7.46K Buy
34
+2
+6% +$434 ﹤0.01% 730
2024
Q1
$7.2K Hold
32
﹤0.01% 724
2023
Q4
$7.04K Sell
32
-7
-18% -$1.48K ﹤0.01% 709
2023
Q3
$8.56K Sell
39
-2
-5% -$452 ﹤0.01% 573
2023
Q2
$9.22K Buy
41
+5
+14% +$1K ﹤0.01% 538
2023
Q1
$6.89K Sell
36
-19
-35% -$3.67K ﹤0.01% 629
2022
Q4
$10.2K Sell
55
-9
-14% -$1.58K ﹤0.01% 480
2022
Q3
$11K Sell
64
-7
-10% -$1.42K ﹤0.01% 398
2022
Q2
$15K Buy
+71
New +$16K ﹤0.01% 333
2021
Q4
$13K Buy
55
+21
+62% +$4.8K ﹤0.01% 424
2021
Q3
$7K Buy
+34
New +$7.28K ﹤0.01% 590

Other funds holding STE

Bell Investment Advisors's STE Position: Q2 2026 in Review

Bell Investment Advisors held its Steris (STE) position steady in Q2 2026 at 26 shares worth $5.47K. The position accounts for ﹤0.01% of the portfolio, ranked #941.

Bell Investment Advisors first reported a position in STE in Q3 2021 and has held it in 19 quarters since. The position peaked at $15K in Q2 2022. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Bell Investment Advisors held 26 shares of Steris worth $5.47K as of Q2 2026.
  • Bell Investment Advisors left its Steris share count unchanged in Q2 2026.
  • Steris made up ﹤0.01% of Bell Investment Advisors's portfolio in Q2 2026, its #941 holding.
  • Bell Investment Advisors first reported a position in Steris in Q3 2021 and has held it in 19 quarters since.
  • Bell Investment Advisors's Steris position peaked at $15K in Q2 2022.
  • 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Bell Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.